The law firm Schall announces that it

LOS ANGELES, May 26, 2024 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims of possible breaches of fiduciary duty by directors and management on behalf of investors in Blueprint Medicines Corporation (“Blueprint” or “the Company”) (NASDAQ: BPMC).

The focus of the investigation is to determine whether Blueprint’s board of directors breached its fiduciary duty to shareholders.

If you are a shareholder, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335 to discuss your rights free of charge. You may also reach us through the firm’s website at www.schallfirm.com or by email at [email protected].

The Schall Law Firm represents investors throughout the world and specializes in securities class action litigation and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under applicable laws and professional rules.

CONTACT:
The Schall Law Firm
Brian Schall, Esq.
310-301-3335
[email protected]
www.schallfirm.com